These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Potential role of calcifying nanoparticles in the etiology of multiple sclerosis. Can Demirdöğen B Med Hypotheses; 2019 Jul; 128():25-27. PubMed ID: 31203904 [TBL] [Abstract][Full Text] [Related]
26. Molecular determinants of extracellular matrix mineralization in bone and blood vessels. Murshed M; McKee MD Curr Opin Nephrol Hypertens; 2010 Jul; 19(4):359-65. PubMed ID: 20489614 [TBL] [Abstract][Full Text] [Related]
28. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. Price PA; Lim JE J Biol Chem; 2003 Jun; 278(24):22144-52. PubMed ID: 12676929 [TBL] [Abstract][Full Text] [Related]
29. Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice. Kaartinen MT; Murshed M; Karsenty G; McKee MD J Histochem Cytochem; 2007 Apr; 55(4):375-86. PubMed ID: 17189522 [TBL] [Abstract][Full Text] [Related]
30. Mud in the blood: the role of protein-mineral complexes and extracellular vesicles in biomineralisation and calcification. Jahnen-Dechent W; Büscher A; Köppert S; Heiss A; Kuro-O M; Smith ER J Struct Biol; 2020 Oct; 212(1):107577. PubMed ID: 32711043 [TBL] [Abstract][Full Text] [Related]
31. von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Bonewald LF; Harris SE; Rosser J; Dallas MR; Dallas SL; Camacho NP; Boyan B; Boskey A Calcif Tissue Int; 2003 May; 72(5):537-47. PubMed ID: 12724828 [TBL] [Abstract][Full Text] [Related]
32. Vascular calcification: pathobiological mechanisms and clinical implications. Johnson RC; Leopold JA; Loscalzo J Circ Res; 2006 Nov; 99(10):1044-59. PubMed ID: 17095733 [TBL] [Abstract][Full Text] [Related]
33. Microvasculopathy and soft tissue calcification in mice are governed by fetuin-A, magnesium and pyrophosphate. Babler A; Schmitz C; Buescher A; Herrmann M; Gremse F; Gorgels T; Floege J; Jahnen-Dechent W PLoS One; 2020; 15(2):e0228938. PubMed ID: 32074140 [TBL] [Abstract][Full Text] [Related]
34. The vascular biology of calcification. Shroff RC; Shanahan CM Semin Dial; 2007; 20(2):103-9. PubMed ID: 17374082 [TBL] [Abstract][Full Text] [Related]
35. Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity. Köppert S; Büscher A; Babler A; Ghallab A; Buhl EM; Latz E; Hengstler JG; Smith ER; Jahnen-Dechent W Front Immunol; 2018; 9():1991. PubMed ID: 30233585 [No Abstract] [Full Text] [Related]
38. Determinants of pathological mineralization. Kirsch T Curr Opin Rheumatol; 2006 Mar; 18(2):174-80. PubMed ID: 16462525 [TBL] [Abstract][Full Text] [Related]
39. Initiation of mineralization in bioprosthetic heart valves: studies of alkaline phosphatase activity and its inhibition by AlCl3 or FeCl3 preincubations. Levy RJ; Schoen FJ; Flowers WB; Staelin ST J Biomed Mater Res; 1991 Aug; 25(8):905-35. PubMed ID: 1918108 [TBL] [Abstract][Full Text] [Related]
40. Cardiac calcifications: Fetuin-A and other risk factors in hemodialysis patients. Coen G; Manni M; Agnoli A; Balducci A; Dessi M; De Angelis S; Jankovic L; Mantella D; Morosetti M; Naticchia A; Nofroni I; Romagnoli A; Gallucci MT; Tomassini M; Simonetti G; Splendiani G ASAIO J; 2006; 52(2):150-6. PubMed ID: 16557100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]